What is Evogene?
Evogene operates at the vanguard of computational chemistry, utilizing sophisticated artificial intelligence to streamline the discovery and design of novel small molecules. The company's core competency lies in its ability to accelerate research and development cycles for both pharmaceutical and agricultural applications. By transforming complex biological data into actionable insights, Evogene bridges the gap between theoretical scientific discovery and commercially viable product development. Its market position is defined by a robust internal innovation pipeline complemented by high-value strategic collaborations that validate its technological efficacy in a competitive landscape.
How much funding has Evogene raised?
Evogene has raised a total of $15M across 2 funding rounds:
Stock Offering
$5M
Share Placement
$10M
Stock Issuance/Offering (2013): $5M, investors not publicly disclosed
Share Placement (2020): $10M led by Alpha Capital Anstalt and ARK Investment Management LLC
Key Investors in Evogene
Alpha Capital Anstalt
A private investment firm focused on long-term capital appreciation and strategic equity positions in innovative technology sectors.
ARK Investment Management LLC
A prominent investment manager specializing in thematic investing and disruptive innovation across global markets.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Evogene?
With the recent influx of capital, Evogene is well-positioned to scale its AI-driven discovery engine, focusing on expanding its footprint in high-growth therapeutic and ag-tech markets. The strategic deployment of these funds will likely prioritize the optimization of its proprietary platform to reduce time-to-market for novel compounds. As the firm transitions into a more mature enterprise-level lifecycle stage, stakeholders can expect an increased emphasis on securing long-term partnerships that leverage its computational expertise to solve critical challenges in molecule design and development.
See full Evogene company page
